CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






5 - Thia - 1 - azabicyclo (4.2.0) oct - 2 - ene - 2 - carboxylic acid, 3 - (hydroxymethyl) - 8 - oxo - 7 - (2 - (2 - thienyl) acetamido) - , acetate, monosodium salt

RTECS #: XI0388300

CAS #: 58-71-9


UPDATE: February 2003 MW: 418.44 MF: C16H15N2O6S2•Na


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. REPRODUCTIVE EFFECTS DATA:
  3. ACUTE TOXICITY DATA:
  4. OTHER MULTIPLE DOSE DATA:
  5. NIOSH DOCUMENTATION AND SURVEILLANCE:
  6. STATUS IN FEDERAL AGENCIES:
  7. REFERENCES:

SYNONYMS:

  1. 7 - (Thiophene - 2 - acetamido) cephalosporanic acid sodium salt
  2. Averon - 1
  3. Cefalothine sodium
  4. Cefalothin sodium
  5. Cefalotina sodica (Spanish)
  6. Cephalothin sodium
  7. Ceporacin
  8. Cepovenin
  9. Chephalotin
  1. Coaxin
  2. Keflin
  3. Lilly 38253
  4. Lospoven
  5. Microtin
  6. Sodium cephalothin
  7. Synclotin
  8. Toricelocin


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
N/R N/R N/R N/R


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
subcutaneous
mouse
lowest published toxic dose: 1,000 mg/kg (9 day pregnant) Reproductive: Effects on embryo or fetus: Fetal death

Reproductive: Other developmental abnormalities
VCVPS* -,392,1998
subcutaneous
mouse
lowest published toxic dose: 1,000 mg/kg (10 day pregnant) Reproductive: Effects on embryo or fetus: Fetal death

Reproductive: Other developmental abnormalities
VCVPS* -,392,1998
subcutaneous
mouse
lowest published toxic dose: 1,000 mg/kg (18 day pregnant) Reproductive: Effects on embryo or fetus: Fetal death

Reproductive: Other developmental abnormalities
VCVPS* -,392,1998


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
child
lowest published toxic dose: 89 mg/kg/19 day- intermittent Blood: Angranulocytosis AACHAX -,272,1963
intramuscular
man
lowest published toxic dose: 955 mg/kg/22 day- intermittent Blood: Angranulocytosis AACHAX -,272,1963
intramuscular
mouse
lethal dose (50 percent kill): >4 gm/kg N/R AMACCQ 1,67,1972
intraperitoneal
mouse
lethal dose (50 percent kill): 5,670 mg/kg Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Skin and Appendages: Other: Hair
JJANAX 27,746,1974
intraperitoneal
rat
lethal dose (50 percent kill): 6,250 mg/kg N/R TXAPA9 18,185,1971
intravenous
cat
lethal dose : >1 gm/kg N/R JIDIAQ 137,S51,1978
intravenous
dog
lowest published lethal dose: 6 gm/kg Eye: Lacrimation

Behavioral: Convulsions or effect on seizure threshold

Gastrointestinal: Nausea or vomiting
JJANAX 28,205,1975
intravenous
guinea pig
lethal dose (50 percent kill): 150 mg/kg Behavioral: Convulsions or effect on seizure threshold CLMEA3 70,1123,1963
intravenous
mouse
lethal dose (50 percent kill): 4,800 mg/kg Eye: Other eye effects

Behavioral: Convulsions or effect on seizure threshold

Skin and Appendages: Other: Hair
JJANAX 27,746,1974
intravenous
mouse
lethal dose (50 percent kill): 5,000 mg/kg N/R VCVPS* -,392,1998
intravenous
rat
lethal dose (50 percent kill): 5,600 mg/kg Eye: Lacrimation

Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Dyspnea
JJANAX 28,231,1975
intravenous
rabbit
lethal dose : >2 gm/kg N/R JIDIAQ 137,S51,1978
intravenous
woman
lowest published toxic dose: 20 mg/kg Blood: Thrombocytopenia AIMEAS 77,401,1972
oral
mouse
lethal dose : >20 gm/kg N/R JJANAX 28,81,1975
oral
rat
lethal dose (50 percent kill): >10 gm/kg N/R JJANAX 27,746,1974
subcutaneous
guinea pig
lethal dose (50 percent kill): 110 mg/kg Behavioral: Convulsions or effect on seizure threshold CLMEA3 70,1123,1963
subcutaneous
mouse
lethal dose (50 percent kill): 7,500 mg/kg N/R JACHDX 6(Suppl A),79,1980
subcutaneous
rat
lethal dose (50 percent kill): 7,500 mg/kg Lung, Thorax, or Respiration: Acute pulmonary edema CLMEA3 70,1123,1963


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
rat
lowest published toxic dose: 48 gm/kg/30 day- intermittent Endocrine: Changes in thyroid weight

Blood: Changes in erythrocyte (RBC) count

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
JJANAX 27,746,1974
intraperitoneal
rat
lowest published toxic dose: 96 gm/kg/30 day- intermittent Liver: Changes in liver weight

Endocrine: Changes in adrenal weight

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
JJANAX 27,746,1974
intraperitoneal
rat
lowest published toxic dose: 78 gm/kg/26 week- intermittent Blood: Other changes

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JJANAX 28,195,1975
intravenous
dog
lowest published toxic dose: 52 gm/kg/30 day- intermittent Gastrointestinal: Nausea or vomiting

Liver: Other changes

Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
JJANAX 28,205,1975
intravenous
dog
lowest published toxic dose: 15 gm/kg/10 day- intermittent Eye: Lacrimation

Gastrointestinal: Changes in structure or function of salivary glands

Gastrointestinal: Nausea or vomiting
JJANAX 28,205,1975
intravenous
rat
lowest published toxic dose: 63 gm/kg/21 day- intermittent Lung, Thorax, or Respiration: Respiratory stimulation

Kidney, Ureter, and Bladder: Changes in bladder weight

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NKRZAZ 26(Suppl 1),185,1978
intravenous
rat
lowest published toxic dose: 72,900 mg/kg/31 day- intermittent Gastrointestinal: Other changes

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
JJANAX 28,231,1975


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 83944;
Number of Industries 1;
Total Number of Facilities 33;
Number of Occupations 1;
Total Number of Employees Exposed 1,650
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 83944;
Number of Industries 1;
Total Number of Facilities 620;
Number of Occupations 11;
Total Number of Employees Exposed 22,644;
Total Number of Female Employees Exposed 18,457


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

EPA GENETOX PROGRAM 1988, Negative: E coli polA without S9


REFERENCES:

CODEN
REFERENCE

AACHAX Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ.
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927-
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
CLMEA3 Clinical Medicine. (Northfield, IL) V.31-33, 1924-26; V.47-85, 1940-78.
JACHDX Journal of Antimicrobial Chemotherapy. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1975-
JIDIAQ Journal of Infectious Diseases. (Univ. of Chicago Press, Journals Div., POB 37005, Chicago, IL 60637) V.1- 1904-
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953-
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959-
VCVPS* "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.

Used as an antibacterial agent

FDA-proprietary drug

RTECS Compound Description:
   Drug
   Mutagen
   Reproductive Effector
   Human Data

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  RTECS List |  Contact Us